MBD3L3

gene
On this page

Summary

MBD3L3 (methyl-CpG binding domain protein 3 like 3, HGNC:37205) is a protein-coding gene on chromosome 19p13.2, encoding Methyl-CpG-binding domain protein 3-like 3 (A6NE82).

Predicted to enable methyl-CpG binding activity. Predicted to be involved in DNA methylation-dependent constitutive heterochromatin formation and negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 653657 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_001164425

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37205
Approved symbolMBD3L3
Namemethyl-CpG binding domain protein 3 like 3
Location19p13.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000182315
Ensembl biotypeprotein_coding
Entrez653657

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000333843, ENST00000689071, ENST00000693237

RefSeq mRNA: 1 — MANE Select: NM_001164425 NM_001164425

CCDS: CCDS45944

Canonical transcript exons

ENST00000333843 — 2 exons

ExonStartEnd
ENSE0000159266770562077056903
ENSE0000169423570585617058676

Expression profiles

Bgee: expression breadth tissue_specific, 10 present calls, max score 93.22.

Top tissues by expression

118 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099193.22gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.38gold quality
left testisUBERON:000453338.81gold quality
granulocyteCL:000009438.37gold quality
bone marrow cellCL:000209238.30gold quality
testisUBERON:000047338.08gold quality
colonic epitheliumUBERON:000039737.20gold quality
ganglionic eminenceUBERON:000402337.14gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
right testisUBERON:000453435.95gold quality
bone marrowUBERON:000237134.16gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
muscle tissueUBERON:000238531.06gold quality
sural nerveUBERON:001548830.93gold quality
prefrontal cortexUBERON:000045130.24gold quality
stromal cell of endometriumCL:000225529.87gold quality
liverUBERON:000210728.53gold quality
duodenumUBERON:000211428.14gold quality
leukocyteCL:000073827.95gold quality
lymph nodeUBERON:000002927.57gold quality
monocyteCL:000057627.31gold quality
primary visual cortexUBERON:000243627.30gold quality
olfactory segment of nasal mucosaUBERON:000538627.28gold quality
tonsilUBERON:000237227.05gold quality
islet of LangerhansUBERON:000000626.99gold quality
frontal cortexUBERON:000187026.81gold quality
urinary bladderUBERON:000125526.61gold quality
endocervixUBERON:000045826.43gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-3929yes4618.75
E-ANND-3no0.98

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

16 targeting MBD3L3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-60799.9773.625593
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-367199.9073.043897
HSA-MIR-313399.8170.923506
HSA-MIR-92A-2-5P99.7567.012164
HSA-MIR-320299.6667.702737
HSA-MIR-5584-5P99.4968.222814
HSA-MIR-751599.3168.221795
HSA-MIR-491-5P99.1365.981468
HSA-MIR-450499.1069.141328
HSA-MIR-394598.6864.21553
HSA-MIR-59598.2567.44699
HSA-MIR-5681A97.9967.171658
HSA-MIR-425397.4865.11692
HSA-MIR-6862-5P97.4864.84713

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriombd3aENSDARG00000061774
mus_musculusMbd3l2ENSMUSG00000047508
rattus_norvegicusMbd3l2ENSRNOG00000026629
rattus_norvegicusMbd3l3ENSRNOG00000065634
drosophila_melanogasterMBD-likeFBGN0027950

Paralogs (8): MBD3 (ENSG00000071655), MBD2 (ENSG00000134046), MBD1 (ENSG00000141644), MBD3L1 (ENSG00000170948), MBD3L2B (ENSG00000196589), MBD3L4 (ENSG00000205718), MBD3L2 (ENSG00000230522), MBD3L5 (ENSG00000237247)

Protein

Protein identifiers

Methyl-CpG-binding domain protein 3-like 3A6NE82 (reviewed: A6NE82)

All UniProt accessions (1): A6NE82

UniProt curated annotations — full annotation on UniProt →

Miscellaneous. The MBD3L proteins are encoded by strongly repeated regions of the 19p13 chromosome. The exact number of functional copies is unclear, and some of them may represent pseudogenes.

Similarity. Belongs to the MBD3L family.

RefSeq proteins (1): NP_001157897* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR025884MeCpG-bd_2/3_C_domDomain
IPR032343MBD2/MBD3_p55-bdDomain

Pfam: PF14048, PF16564

UniProt features (1 total): chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NE82-F166.820.17

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 15 (showing top): GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_DNA_METHYLATION_DEPENDENT_CONSTITUTIVE_HETEROCHROMATIN_FORMATION, GOBP_CHROMATIN_REMODELING, GOBP_HETEROCHROMATIN_ORGANIZATION, GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, chr19p13, GOMF_METHYL_CPG_BINDING, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, MIR92A_2_5P, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION, GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION, GOBP_CHROMATIN_ORGANIZATION, GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS

GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), DNA methylation-dependent constitutive heterochromatin formation (GO:0006346)

GO Molecular Function (2): methyl-CpG binding (GO:0008327), protein binding (GO:0005515)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of transcription by RNA polymerase II1
transcription by RNA polymerase II1
negative regulation of DNA-templated transcription1
constitutive heterochromatin formation1
nucleotide binding1
sequence-specific DNA binding1
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

258 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MBD3L3LEUTXA8MZ59580
MBD3L3PRAMEF15P0DUQ1571
MBD3L3PRAMEF25A6NGN4540
MBD3L3TRIM49P0CI25513
MBD3L3A0A096LNW4A0A096LNW4507
MBD3L3DUXAA6NLW8507
MBD3L3OR4F17Q8NGA8507
MBD3L3DUXBA0A1W2PPF3503
MBD3L3H3Y1P0DPK2496
MBD3L3TRIM43Q96BQ3480
MBD3L3ZSCAN4Q8NAM6480
MBD3L3TRIM43BA6NCK2447
MBD3L3RFPL4BQ6ZWI9446
MBD3L3H3Y2P0DPK5437
MBD3L3ZNF566Q969W8431

IntAct

4 interactions, top by confidence:

ABTypeScore
MBD3L3TRIML2psi-mi:“MI:0915”(physical association)0.560
MBD3L3TRIML2psi-mi:“MI:0915”(physical association)0.000

BioGRID (1): MBD3L3 (Two-hybrid)

ESM2 similar proteins: A0A1B0GVZ6, A5D7I0, A6H7B4, A6NDZ8, A6NE82, A6NJ08, A6NJB7, A6NJI1, A6NL46, A6QP24, A8MUA0, A8MUI8, A8MV72, A8MX80, B2RW88, O94850, P0C6A0, P24097, P50617, Q0P5M0, Q0VD86, Q2KIL8, Q3B8N5, Q3SY00, Q3SYA9, Q3UN58, Q5BMD4, Q5JTZ5, Q5RBE4, Q5VZ46, Q66MI6, Q68US1, Q6GQV0, Q6PAC4, Q80TS7, Q80VY2, Q8BFY7, Q8BII1, Q8IXW0, Q8K2F3

Diamond homologs: A0A1B0GVZ6, A6NDZ8, A6NE82, A6NJ08, O95983, Q8NHZ7, Q8WWY6, Q9D9H3, Q9UBB5, Q9Z2D8, Q9Z2E1, O95243, P51608, Q00566, Q95LG8, Q9UIS9, Q9Z2D6, Q9Z2D7, Q9Z2E2, Q9FZP6, Q9LTJ1, Q9LYB9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

80 predictions. Top by Δscore:

VariantEffectΔscore
19:7056899:TTCCC:Tacceptor_gain1.0000
19:7056901:CCC:Cacceptor_gain1.0000
19:7056902:CCC:Cacceptor_gain1.0000
19:7056903:CCT:Cacceptor_gain1.0000
19:7056904:C:CCacceptor_gain1.0000
19:7056905:T:Cacceptor_gain1.0000
19:7056908:C:CTacceptor_gain1.0000
19:7056909:A:Tacceptor_gain1.0000
19:7058557:TCA:Tdonor_loss1.0000
19:7058558:CACCA:Cdonor_loss1.0000
19:7058559:A:ACdonor_gain1.0000
19:7058559:ACCAG:Adonor_loss1.0000
19:7058560:C:CGdonor_loss1.0000
19:7058560:C:CTdonor_gain1.0000
19:7056901:CCCCT:Cacceptor_gain0.9900
19:7056902:CC:Cacceptor_gain0.9900
19:7056904:C:Tacceptor_gain0.9900
19:7056905:T:TCacceptor_gain0.9900
19:7058555:A:ACdonor_gain0.9900
19:7058556:C:CCdonor_gain0.9900
19:7058556:CTCA:Cdonor_gain0.9900
19:7058559:AC:Adonor_gain0.9900
19:7058560:CC:Cdonor_gain0.9900
19:7058560:CCAG:Cdonor_gain0.9900
19:7058560:CCAGA:Cdonor_gain0.9900
19:7056900:TCCC:Tacceptor_gain0.9800
19:7058556:CT:Cdonor_gain0.9700
19:7058560:CCA:Cdonor_gain0.9700
19:7056900:TCCCC:Tacceptor_gain0.9500
19:7056906:T:TCacceptor_gain0.9500

AlphaMissense

1337 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:7056778:G:CF57L0.947
19:7056778:G:TF57L0.947
19:7056780:A:GF57L0.947
19:7056787:G:CS54R0.916
19:7056787:G:TS54R0.916
19:7056789:T:GS54R0.916
19:7056391:C:AR186S0.898
19:7056391:C:GR186S0.898
19:7056791:G:AT53I0.887
19:7056415:C:AQ178H0.874
19:7056415:C:GQ178H0.874
19:7056779:A:GF57S0.866
19:7056764:G:AT62I0.855
19:7056392:C:AR186M0.843
19:7056758:A:GI64T0.842
19:7056782:A:GI56T0.832
19:7056796:T:AR51S0.824
19:7056796:T:GR51S0.824
19:7056375:C:GA192P0.809
19:7056779:A:CF57C0.808
19:7056881:A:GM23T0.806
19:7056396:C:GA185P0.803
19:7056788:C:AS54I0.797
19:7056425:A:GI175T0.791
19:7056371:A:GL193S0.781
19:7056392:C:GR186T0.777
19:7056440:A:TV170E0.775
19:7056691:T:AQ86H0.769
19:7056691:T:GQ86H0.769
19:7056786:A:GC55R0.765

dbSNP variants (sampled 300 via entrez): RS1002081621 (19:7056684 C>T), RS1002711986 (19:7055876 C>T), RS1002733154 (19:7055737 C>G,T), RS1003469872 (19:7058474 A>G), RS1005935452 (19:7060454 T>A), RS1006970306 (19:7056022 G>A,C,T), RS1010686627 (19:7056654 A>G), RS1011072542 (19:7056270 A>G), RS1012042347 (19:7055716 G>A), RS1014511248 (19:7056770 G>A,C), RS1014543743 (19:7060343 T>A), RS1017025852 (19:7060457 A>G,T), RS1017978500 (19:7056030 A>G,T), RS1018448564 (19:7055920 C>A), RS1021282934 (19:7059836 C>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cadmiumdecreases expression, increases abundance1
Valproic Aciddecreases methylation1
Aflatoxin B1decreases methylation1
Cadmium Chloridedecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.